Specialist biotechnology company delivering therapeutic actives in the field of cannabinoids derived from climate-controlled medical Cannabis sativa and alkaloids derived from Sceletium tortuosum (Kanna). We manufacture, export, and solve cannabinoid therapies in Australia, Germany, the UK, and South Africa. We offer a source-to-shelf full-suite private-label solution for cannabinoid inhalation cartridges and pharmacy syringe compound kits. See the website for more details. We also sell our in-house manufactured and formulated generic brands that include full-spectrum THC concentrate, broad-spectrum THC distillate, and, THC API. For immediate patient solutions, we offer off-the-shelf GESLabs developed inhalation cartridges and pharmacy compound kits. See the website for more details. Cost-Effective, High-Quality, and PICs/EU GMP-accredited. Developed for patients, trusted by doctors, and used by pharmacists. We believe in harnessing nature's naturally readily abundant active therapies transformed with today’s scientific discoveries.